50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

Fraud case against Theranos' Holmes goes to jury

Published 12/17/2021, 03:56 PM
Updated 12/17/2021, 08:36 PM
© Reuters. Theranos founder Elizabeth Holmes listens as Assistant U.S. Attorney Jeff Schenk delivers closing arguments in her fraud trial at federal court in San Jose, California, U.S., December 16, 2021 in this courtroom sketch.  REUTERS/Vicki Behringer

By Jody Godoy

SAN JOSE, Calif. (Reuters) -Jurors began weighing the fate of Theranos founder Elizabeth Holmes' on Friday, after the prosecution and defense painted very different pictures of the entrepreneur who once dazzled Silicon Valley and is now charged with fraud.

In the final hours of a trial that has spanned three months, Assistant U.S. Attorney John Bostic said Holmes embraced dishonesty in an attempt to save the blood testing startup.

"She committed these crimes because she was desperate for the company to succeed," he said.

After receiving the case on Friday, the jury went home for the evening. They were due to return on Monday.

Holmes believed Theranos would change medicine with small machines that could run a wide range of blood tests on a few drops from a finger prick, her lawyers have said, arguing the company's failure was not a crime.

But prosecutors say Holmes lied to investors and retail customers, including by overstating what Theranos' machines were capable of and the accuracy of its tests. She faces nine counts of fraud and two counts of conspiracy.

The meteoric rise and spectacular fall of Theranos turned Holmes from a young billionaire into a defendant who could face years in prison if convicted.

Once valued at $9 billion, Theranos collapsed after the Wall Street Journal published a series of articles, starting in 2015, that suggested its devices were flawed and inaccurate.

© Reuters. Theranos founder Elizabeth Holmes listens as Assistant U.S. Attorney Jeff Schenk delivers closing arguments in her fraud trial at federal court in San Jose, California, U.S., December 16, 2021 in this courtroom sketch.  REUTERS/Vicki Behringer

Holmes' attorney Kevin Downey said the evidence did not show Holmes was motivated by a cash crunch at Theranos, but rather thought she was "building a technology that would change the world."

"You know that at the first sign of trouble, crooks cash out," but Holmes stayed, Downey said. "She went down with that ship when it went down."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.